We’re now almost halfway through 2022, and psychedelic research shows no signs of slowing down. Over May, we continued to gain a better understanding of how psychedelics work in the brain while new scales to measure aspects of the psychedelic experience were developed. Several potential new indications for psychedelic medicine were also put forward. Several studies published over the month of May…


Previous articlePT323 – Dr. Reid Robison & Steve Thayer, Ph.D. – Ketamine-Assisted Psychotherapy, Therapist Burnout, and LSD for Anxiety
Next articlePT324 – Amanda Reiman, Ph.D., MSW – Web3, NFTs, Cryptocurrencies, and A Deeper Relationship With Plants